Storage Trends for 2018: Cloud Storage 2.0 Players Poised to Ascend

In March 2006, Amazon launched Simple Storage Service (S3). Although few people paid much attention at the time, the announcement of S3 marked the beginning of a great migration of data from on-premises storage to the cloud. The first generation of cloud storage products—as represented by Amazon S3, Google Cloud, and Microsoft Azure—made the best … Continue reading “Storage Trends for 2018: Cloud Storage 2.0 Players Poised to Ascend”

Family & Kids’ Advocate Shum Preston on the Tech Backlash of 2017

Much attention was focused this past year on the impact of social media on the 2016 presidential election, as reports emerged about the use of these platforms by entities linked with Russia to spread false, misleading, or inflammatory political messages. Aside from these revelations about “fake news,” the year brought reports on major data breaches … Continue reading “Family & Kids’ Advocate Shum Preston on the Tech Backlash of 2017”

Houston Investor Murthy Reflects on Tech’s High & Low Points in 2017

A series of events this year—from the Equifax data breach to the foreign use of social media to influence the U.S. presidential election—has prompted some to question the utopian promise of innovation, especially when it comes to Web companies and cybersecurity. To help put things in perspective at year’s end, Xconomy reached out to Neal … Continue reading “Houston Investor Murthy Reflects on Tech’s High & Low Points in 2017”

Security Evangelist Tony Anscombe on the Tech Backlash of 2017

It’s time to ring out the old year. Or perhaps in the case of 2017, with its litany of data security breaches, social media manipulations, and allegations of sexual harassment, to just wring out the old. As the year drew to a close, Xconomy asked a variety of tech industry observers for their perspective on … Continue reading “Security Evangelist Tony Anscombe on the Tech Backlash of 2017”

Tech Industry Must Implement Old-School Corporate Best Practices

There is little doubt that Silicon Valley has taken a reputational hit in 2017, partly as a result of the media’s usual star-making and -breaking process, but mostly through self-inflicted wounds. However, while specific details in the press may be shocking, the problems were predictable: Bad behavior often follows when there is an imbalance in … Continue reading “Tech Industry Must Implement Old-School Corporate Best Practices”

UTD’s Guengerich on the Promise and Peril of Tech Innovation in 2017

A series of events this year—from the Equifax data breach to the foreign use of social media to influence the U.S. presidential election—has prompted some to question the utopian promise of innovation, especially when it comes to Web companies and cybersecurity. To help put things in perspective at year’s end, Xconomy reached out to Steve … Continue reading “UTD’s Guengerich on the Promise and Peril of Tech Innovation in 2017”

Tamr’s Andy Palmer on Diversity in Tech & A.I.’s Data Challenge

As 2017 comes to a close, we’re surveying business and technology leaders from around our network to get their perspectives on the year in tech—and what’s next. Below are the highlights from our e-mail exchange with entrepreneur and investor Andy Palmer, the co-founder and CEO of Cambridge, MA-based Tamr, a “data unification” software company. (Palmer … Continue reading “Tamr’s Andy Palmer on Diversity in Tech & A.I.’s Data Challenge”

WatchHerWork CEO Hamilton: “We Are All Ready for Tech to Grow Up”

A series of highly publicized events in 2017—from the Equifax data breach to the exposure of rampant sexual harassment in parts of the tech industry—has prompted some to question the utopian promise of innovation, especially when it comes to cybersecurity and tech culture. In a bid to put things in perspective at year’s end, Xconomy … Continue reading “WatchHerWork CEO Hamilton: “We Are All Ready for Tech to Grow Up””

Privacy Advocate Richard Holober on the Tech Backlash of 2017 

We’ve just passed a year full of news about the role of technology companies in U.S. elections, democracy, free speech, fairness in hiring, sexual harassment, privacy, data security, and the future job market for humans in the age of robots and artificial intelligence. Speculation is rampant about a possible sea change in consumer attitudes toward … Continue reading “Privacy Advocate Richard Holober on the Tech Backlash of 2017 “

Despite Scandal-Filled Year, Mark Cuban Says “Tech Is Just Tech”

A series of highly publicized events this year—from the Equifax and Uber data breaches to foreign use of social media and Web services to influence the U.S. election—has prompted some to question the utopian promise of innovation, especially when it comes to cybersecurity and big tech companies. In a bid to put things in perspective … Continue reading “Despite Scandal-Filled Year, Mark Cuban Says “Tech Is Just Tech””

Flipside Crypto’s Balter Talks Uber, #MeToo, Cryptocurrencies

The past year was a turbulent one for the tech industry. There was a new controversy seemingly every week, whether it was Uber’s myriad scandals; more personal data breaches; Russia’s use of social media and other online platforms to try and influence U.S. voters; growing concerns over tech giants’ power; and a series of sexual … Continue reading “Flipside Crypto’s Balter Talks Uber, #MeToo, Cryptocurrencies”

Cybersecurity Expert Ash Mozano on the Tech Backlash of 2017

There may be nothing more subjective than trying to gauge public attitudes about technology. Yet a series of highly publicized events in 2017—from the massive exposure of personal data in the Equifax breach to the use of Twitter and Facebook to manipulate voters in the U.S. Presidential election—has prompted some to question the utopian promise … Continue reading “Cybersecurity Expert Ash Mozano on the Tech Backlash of 2017”

Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More

[Updated 12/22/17, 2:37 p.m. See below.] This year is wrapping up as one of the strongest on record for FDA drug approvals. As of this morning, the regulator has approved 46 novel drugs in 2017—a total that beats the mark set two years ago. With one week left in the year, the FDA could add … Continue reading “Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More”

EnsoData, Pyxsee, Epic, & More: This Week’s Wisconsin Watchlist

As you get set to head into the final week of 2017, take a few minutes to catch up on news from Wisconsin’s innovation community with these recent headlines: —EnsoData, a Madison-based startup developing software to help clinicians analyze sleep data and diagnose patients with sleep apnea and other disorders, raised nearly $1 million in … Continue reading “EnsoData, Pyxsee, Epic, & More: This Week’s Wisconsin Watchlist”

Fintech in 2018: Blockchain Apps, A.I. Interfaces, Crypto Rules

For the financial technology sector, the year’s headlines were dominated by breathless blockchain hype, cryptocurrency bubble talk, and a never-ending barrage of initial coin offerings. To help put things in perspective—and get a read on what might come next in fintech—Xconomy caught up with David Jegen (pictured), a Boston-based partner with F-Prime Capital, who invests … Continue reading “Fintech in 2018: Blockchain Apps, A.I. Interfaces, Crypto Rules”

Goods Unite Us Develops App to Shed Light on Money in Politics

Less than two weeks after last November’s presidential election, Penzeys Spices CEO Bill Penzey Jr. wrote a public Facebook (NASDAQ: [[ticker:FB]]) post excoriating Donald Trump and voters who supported him. “You just voted for an openly racist candidate for the presidency of the United States of America,” Penzey wrote in the post. Some left-leaning voters … Continue reading “Goods Unite Us Develops App to Shed Light on Money in Politics”

Social Media Cyber Threats: 3 Predictions for 2018

1. Ransomware: Social media will be the number one vehicle for ransomware distribution in 2018. Currently, there are nearly 1 million social media accounts compromised every day, and that number will continue to rise, thanks to the plethora of easily identifiable targets. And with new channels comes new costs: the average cost of a ransomware ticket will go up … Continue reading “Social Media Cyber Threats: 3 Predictions for 2018”

Net Neutrality Repeal Means The Battle Is Just Beginning

From businesses and consumers to politicians and tech industry leaders, the furor over last week’s Federal Communications Commission (FCC) decision to repeal net neutrality can be felt across America. People everywhere are stepping up to show their support for a free and open Internet. In my view, the battle to preserve net neutrality is still … Continue reading “Net Neutrality Repeal Means The Battle Is Just Beginning”

Retailers’ Holiday Wishlist? More Sales Powered By New Technologies

From products designed by artificial intelligence to virtual reality systems that help shoppers picture merchandise in their homes, retailers are deploying technology like never before this holiday season, betting that they can win business back from the default of online shopping. These innovations run the gamut, including sensors and cameras that can monitor in-store movements, … Continue reading “Retailers’ Holiday Wishlist? More Sales Powered By New Technologies”

After gBETA, UW Professor’s Latest Startup Aims to Ride Chatbot Wave

Virtual assistants have come a long way in the two decades since Microsoft (NASDAQ: [[ticker:MSFT]]) introduced Clippit, an animated paper clip that suggested tips and shortcuts to users as they worked in Word, Excel, and other Microsoft Office applications. The bot, commonly known as “Clippy,” drew endless ire and mockery—even from Microsoft—before the company retired … Continue reading “After gBETA, UW Professor’s Latest Startup Aims to Ride Chatbot Wave”

3 A.I. Predictions for 2018: Emotion, Data, Ethics

1. Emotion A.I. will increase our humanity and empathy for each other. In recent years, the smartphones, bots, and devices we spend so much of our time with could be accused of contributing to the desensitization of our society. When a fight breaks out, some teens’ first reaction is to pull out their phones and take … Continue reading “3 A.I. Predictions for 2018: Emotion, Data, Ethics”

Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More

In the penultimate week before the end-of-year recess, Congress raced to provide the drug industry—and the rest of corporate America—a massive tax cut, with breaks for investors, too. Racing to finish their own end-of-year budgets, perhaps, investors poured hundreds of millions into private biotechs, too. If that doesn’t get your blood racing, then how about … Continue reading “Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More”

American Family Buys Chicago Firm to Expand Analytics, A.I. Use

In recent years, American Family Insurance has spent significant amounts of money and time developing new technologies it believes could improve customers’ lives, as well as the Madison, WI, company’s bottom line. These investments have been both internal—for example, ramping up the use of data analytics and artificial intelligence to assess risk and price policies—and … Continue reading “American Family Buys Chicago Firm to Expand Analytics, A.I. Use”

D2P Shifts Focus, as Fund for Investing in UW Entrepreneurs Dries Up

[Updated 12/15/17 2:51 p.m. See below.] Since its launch four years ago, a University of Wisconsin-Madison program has been working with students, faculty, and staff at the school to turn their ideas into startup companies. But now the program, known as Discovery to Product (D2P) has nearly exhausted the $2.4 million “Igniter” fund D2P has … Continue reading “D2P Shifts Focus, as Fund for Investing in UW Entrepreneurs Dries Up”

Gene Therapy Advances, But Hemophilia Is No Easy Target

Mark Skinner, the former longtime president of the World Federation of Hemophilia, has had the blood disease on his mind his entire life. He doesn’t have a choice. Skinner, 57, was born with a severe form of hemophilia A, meaning he has a tiny fraction of the necessary cellular machinery to clot blood. His disease … Continue reading “Gene Therapy Advances, But Hemophilia Is No Easy Target”

EmOpti Aims to Help Patients in ER Get Seen by Doctors More Quickly

Ed Barthell doesn’t mince words when describing the poor experiences many patients have when they go to the emergency room. “Emergency medicine is still an industry that essentially delivers lousy service for really high cost,” says Barthell, a doctor who worked in the ER for more than two decades before leaving his clinical practice in … Continue reading “EmOpti Aims to Help Patients in ER Get Seen by Doctors More Quickly”

ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More

[Updated, 12/13/17, 1:50 p.m. ET. See below.] The annual American Society of Hematology meeting is nearly over. For now, we’ve chosen updates from three disease areas to highlight, plus the more notable market movements. No surprise, there’s a lot about the genetically engineered cell therapy known as CAR-T. Gene therapy and more standard forms of … Continue reading “ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More”

What Are the Nation’s Top Cities and Regions for Driverless Tech?

Whether you think self-driving cars are the stuff of science fiction or a potentially paradigm-shifting new form of transportation, autonomous vehicles are coming—and the companies developing them are spending big money to make it happen. A few years ago, industry analysts seemed to think Silicon Valley would win the race to get self-driving cars on … Continue reading “What Are the Nation’s Top Cities and Regions for Driverless Tech?”

Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist

Keep up with the latest news from Wisconsin’s innovation community with these recent headlines: —The Scientist magazine named Fitchburg-based Promega’s “High BiT” protein-tagging system as one of its top 10 innovations of 2017. The product emits a bright light, allowing researchers to “quantify the abundance of a protein of interest, whether it be in the … Continue reading “Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist”

Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More

With 2018 around the corner, this was a week to look ahead. At Xconomy, we zeroed in on several clinical trials that could become major stories in the life sciences. Other healthcare milestones are on the way, too. The FDA will consider for the first time whether a video game should be approved as medicine. … Continue reading “Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More”

The ‘Amazon Effect’ and the Gender Wage Gap

The battle to land Amazon’s second home is shaping up to be one of the fiercest competitions to lure a corporate headquarters in modern history. From serious incentives like massive tax breaks to headline grabbing stunts like offers of bear wrestling and giant cacti, it’s safe to say cities are pulling out every stop imaginable … Continue reading “The ‘Amazon Effect’ and the Gender Wage Gap”

Arrowhead Pharma Reveals Data It Hopes Will Aid New Hepatitis B Drug

Arrowhead Pharmaceuticals (NASDAQ: [[ticker:ARWR]]) suffered a major setback last year after it canceled the development of three experimental drug candidates for liver disease. On Wednesday, Pasadena, CA-based Arrowhead—which houses its research and development operations in Madison, WI—shared data from a study involving one of the canceled drug candidates that the company believes could bode well … Continue reading “Arrowhead Pharma Reveals Data It Hopes Will Aid New Hepatitis B Drug”

Ionic Unveils New App-Making Tools, Continues Push to Make Money

Ionic has introduced a new set of tools for developing mobile software applications, as the Madison, WI-based startup continues its effort to create revenue streams off of its sizeable user base. The new suite of development tools, known as Ionic Pro, is aimed at helping developers build, test, and distribute apps faster and more easily … Continue reading “Ionic Unveils New App-Making Tools, Continues Push to Make Money”

Propose With a Lab-Made Diamond? Diamond Tech Retailers Say, “Yes”

How do you disrupt an industry that markets itself as the embodiment of “forever?” You bring it back to basics, says Lindsay Reinsmith, co-founder of Ada Diamonds, an online retailer of jewelry with lab-made gemstones in San Francisco. “Science is on our side,” she says. “We confront them with facts.” Machine-made gemstones are created in exactly … Continue reading “Propose With a Lab-Made Diamond? Diamond Tech Retailers Say, “Yes””

15 For ’18: Key Clinical Data to Watch For Next Year (Part 2)

[Corrected, 12/11/17, 1 p.m. ET. See below.] On Monday we posted the first part of our look at what should be some of 2018’s most important clinical data, including trials for lung cancer, heart disease, melanoma, Alzheimer’s disease, rare blood disorders, and more. With part two, we’re previewing studies for migraine, brain cancer, lymphoma, peanut … Continue reading “15 For ’18: Key Clinical Data to Watch For Next Year (Part 2)”

American Family to Launch Moonrise, a Platform for Moonlighting

[Updated 12/6/17 11:43 a.m. See below.] Retailers across the U.S. often hire additional workers this time of year to help get them through the busy holiday shopping season. Allowing employers to bring in extra help during busy times is likewise the idea behind Moonrise, a Chicago-based startup that recently exited stealth mode. According to its … Continue reading “American Family to Launch Moonrise, a Platform for Moonlighting”

Case’s $150M Rise of the Rest Fund Aims to Boost Flyover Startups

Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful entrepreneurs in the country. Called the Rise of the Rest Seed Fund, it will … Continue reading “Case’s $150M Rise of the Rest Fund Aims to Boost Flyover Startups”

Black Venture Capitalists Are Transforming Tech

Would it surprise you to know that there are more than 100 black venture capitalists or that this nationwide ecosystem is growing? Most of the VCs in this expanding ecosystem made pivots from highly successful careers in other fields. They have very impressive academic credentials, business backgrounds comparable to their Silicon Valley peers, and a … Continue reading “Black Venture Capitalists Are Transforming Tech”

15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)

Many of biotech’s biggest stories in 2017 followed the highly anticipated data from clinical studies. There were monumental successes, like the first-ever approval of a genetically modified living cell therapy, the first FDA application for a gene therapy or a medicine using RNA interference. There were also stinging failures, such as the latest in a long … Continue reading “15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)”

Stonehouse, AkitaBox, Iverson, & More: This Week’s WI Watchlist

Stay current on the latest news from Wisconsin’s innovation community with these recent headlines: —Stonehouse Water Technologies, a Milwaukee-based startup developing energy-efficient water purification systems, said it raised more than $1.5 million from investors. Launched in 2012, Stonehouse is developing a water purifier about the size of a dehumidifier that’s designed for use in residential, … Continue reading “Stonehouse, AkitaBox, Iverson, & More: This Week’s WI Watchlist”

Milestones of Innovation 15: Entering the New Atomic World

A momentous step into the atomic age happened around 3:20 p.m. Central War Time on Dec. 2, 1942, seventy-five years ago, in a vast, unheated space (a former squash doubles court) under the abandoned University of Chicago football stands at Stagg Field. A cadmium control rod was pulled out from a huge, painstakingly assembled cube … Continue reading “Milestones of Innovation 15: Entering the New Atomic World”

Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More

A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency of headaches. These drugs still await an FDA decision, and their impact on patients over the long term are being watched closely. As many as 38 million Americans suffer from migraines, according … Continue reading “Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More”

Former GE CEO Immelt Talks Uber, A.I., and a Rejected Bid for Epic

Artificial intelligence holds promise for healthcare in areas like radiology, but it could be tough sledding for businesses selling narrowly focused products to one customer at a time. The winners in this emerging sector will figure out how to integrate A.I. tools into a broader platform that offers clear value for doctors, hospitals, insurers, and … Continue reading “Former GE CEO Immelt Talks Uber, A.I., and a Rejected Bid for Epic”

Business Leaders: Foxconn Plant Could Benefit WI Startups, Lure VC

Local startup companies could be among the beneficiaries of a 25 million-square-foot manufacturing facility that Foxconn, a Taiwanese electronics assembly giant, intends to build in southeastern Wisconsin, according to state economic development officials. Foxconn, which is perhaps best known as a key supplier for Apple (NASDAQ: [[ticker:AAPL]]) and other device makers, in July announced plans … Continue reading “Business Leaders: Foxconn Plant Could Benefit WI Startups, Lure VC”

“Responsive” Machine Learning Could Lessen Cybersecurity Tradeoffs

In the wake of the Equifax breach and the global WannaCry ransomware outbreak earlier this year, tensions around cybersecurity are running high. According to a recent study conducted by the Ponemon Institute and sponsored by Barkly, seven out of 10 organizations are reporting their security risk has significantly increased during the past 12 months. Only … Continue reading ““Responsive” Machine Learning Could Lessen Cybersecurity Tradeoffs”

Drug Prices, Industry Ties Take Spotlight at HHS Nominee Azar Hearing

If Wednesday’s hearing for Health and Human Services Secretary Nominee Alex Azar is any indication, reining in drug prices and insurance premiums are the policy priorities that will guide Congress’s interaction with the department under a new leader. For the better part of the three-hour hearing by the Senate’s Health, Education, Labor and Pensions committee, … Continue reading “Drug Prices, Industry Ties Take Spotlight at HHS Nominee Azar Hearing”

CFO: Exact in ‘Investment Mode,’ Seeks to Advance New Cancer Tests

Shares in Exact Sciences have more than quadrupled in 2017, and the stock’s impressive run has led some analysts to question whether it’s a smart buy at the current price. But Jeff Elliott, Exact’s chief financial officer, says he believes his company is poised for continued growth as it adds laboratory space and works to … Continue reading “CFO: Exact in ‘Investment Mode,’ Seeks to Advance New Cancer Tests”

Joining Trend, WI Creates New Business Entity: Benefit Corporations

On Monday, Wisconsin enacted legislation allowing companies to incorporate as benefit corporations. Although this may sound like routine, small-time legislative business, it is just as significant as major policy initiatives being debated in the halls of Congress. On issues from net neutrality to workers’ rights, corporations are perceived to—and often do—engage in practices that maximize … Continue reading “Joining Trend, WI Creates New Business Entity: Benefit Corporations”